Cortex Pharmaceuticals (RSPI) Stock Chart & Stock Price History $0.0015 +0.00 (+25.00%) As of 03:16 PM Eastern Add Compare Share Share Chart Stock AnalysisChartSEC FilingsShort InterestBuy This Stock Cortex Pharmaceuticals Stock Price Performance The Cortex Pharmaceuticals (RSPI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 275.00%, with a year-to-date return of 87.50%. In the past month, the stock has increased 150.00%, reflecting recent market activity. As of the latest close, Cortex Pharmaceuticals traded at $0.00 with a market cap of $1.42 million and volume of 4,598 shares. Five years ago, the stock traded at $0.01, representing a 79.73% decrease over that period. At the time, it had a market cap of $2.04 million and a volume of 14.33 million shares. Receive RSPI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cortex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance+150.00%3 Month Performance-28.57%Year-To-Date Performance+87.50%1 Year Performance+275.00%5 Year Performance-79.73% RSPI Stock Chart for Monday, July, 28, 2025 RSPI Chart by TradingView Cortex Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/25/2025$0.00$0.00$0.00$0.004,598 shs$1.42 million07/24/2025$0.00$0.00$0.00$0.005,000 shs$1.42 million07/23/2025$0.00$0.00$0.00$0.0012,000 shs$1.42 million07/22/2025$0.00$0.00+25.00%$0.00$0.005,500 shs$1.42 million07/21/2025$0.00$0.00-20.00%$0.00$0.004,100 shs$1.14 million07/18/2025$0.00$0.00$0.00$0.0012,000 shs$1.42 million07/17/2025$0.00$0.00+114.29%$0.00$0.006,900 shs$1.42 million07/16/2025$0.00$0.00$0.00$0.002.00 million shs$665,000.0007/15/2025$0.00$0.00$0.00$0.00305,000 shs$665,000.0007/14/2025$0.00$0.00-36.36%$0.00$0.00305,000 shs$665,000.00 Get the Latest News and Ratings for RSPI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cortex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/11/2025$0.00$0.00-26.67%$0.00$0.001.47 million shs$1.04 million07/10/2025$0.00$0.00+114.29%$0.00$0.00499,700 shs$1.42 million07/09/2025$0.00$0.00$0.00$0.0024,224 shs$665,000.0007/08/2025$0.00$0.00-53.33%$0.00$0.0024,224 shs$665,000.0007/07/2025$0.00$0.00+87.50%$0.00$0.00598,229 shs$1.42 million07/04/2025$0.00$0.00$0.00$0.005,000 shs$760,000.0007/03/2025$0.00$0.00-11.11%$0.00$0.005,000 shs$760,000.0007/02/2025$0.00$0.00-40.00%$0.00$0.00405,300 shs$855,000.0007/01/2025$0.00$0.00+150.00%$0.00$0.00800 shs$1.42 million06/30/2025$0.00$0.00$0.00$0.00800 shs$570,000.0006/27/2025$0.00$0.00$0.00$0.00435,010 shs$570,000.00 Related Companies BCTX Stock Price Chart KTTA Stock Price Chart PLRZ Stock Price Chart ENSC Stock Price Chart VIVS Stock Price Chart GLTO Stock Price Chart GRI Stock Price Chart REVB Stock Price Chart THAR Stock Price Chart SNGX Stock Price Chart Receive RSPI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cortex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:RSPI) was last updated on 7/28/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s $100 Trillion Land Rush Is OnWhat Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trill...Stansberry Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTop 10 Green Zone Stocks to Buy NowOthers have paid $2,000 for access to stock picks like these—this weekend, you can get them free. Using a p...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cortex Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cortex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
